Relmada Therapeutics (RLMD) Misses Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: RLMD) | Delayed: 3.29 +0.08 (2.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.21 | 52 Week High | $4.10 | |||
| Open | $3.27 | 52 Week Low | $0.87 | |||
| Day High | $3.41 | P/E | N/A | |||
| Day Low | $3.15 | EPS | $0.00 | |||
| Volume | 6,281,107 | |||||
